Daily Stock List
One World Holdings, Inc. (OWOO)
PennyStock24, OtcWizard, MoneyTV, FeedBlitz, and Real Pennies reported earlier on One World Holdings, Inc. (OWOO), and we highlight the Company today, here at the QualityStocks Daily Newsletter.
One World Holdings, Inc. is an OTCQB-listed development stage company, which focuses on the design, production, and marketing of dolls. The Company has a platform to become the foremost provider of multi-cultural doll products to the specialty, affinity, as well as mass merchandise retail marketplace through a focus of direct and online sales platforms.
One World Holdings’ plan is to offer a range of mainstream multicultural dolls to high-end collectors and young pre-teen girls. The Company’s first line of dolls are The Prettie Girls™. The Prettie Girls! OWP doll line is unique in their look, their backgrounds, and their stories. One World Holdings has their headquarters in Houston, Texas.
The Company has merged a play model with a socially impactful message for young girls and their self-image awareness and development. The One World Doll Project is a subsidiary of One World Holdings. For young girls, The One World Doll Project will create a doll that is a friend, a partner in play, and a glimpse of their biggest, brightest dreams. For young women, it is a keepsake of one of the best times of their lives. For collectors, The One World Doll Project promises stylish works of art that the Company believes will become a vital part of a valuable growing collectors’ market.
The One World Doll Project is a movement to influence a more positive self-image among young women and girls worldwide. Their overall vision is to introduce a new way mainstream dolls are designed, marketed, and integrated into the fabric of America. The One World Doll Project's central mission is to make one of the most significant, positive cultural impacts on play and in the doll category in recent history.
In late August, The One World Doll Project announced that they partnered with Mr. Steve Varner of Varner Studios for all 3D modeling and sculpture work on the Company’s forthcoming line of celebrity dolls.
Ms. Joanne Melton, Chief Executive Officer of One World Holdings, said, "When we first partnered with Steve Varner during the development of The Prettie Girls! Dolls, we immediately understood why his name is associated with so many successful toy products including Star Trek, Lara Croft Tomb Raider, The Teenage Mutant Ninja Turtles, McDonald's Happy Meals and more. His work has always been of the highest quality and we are thrilled to once again have him as a part of the One World Team."
One World Holdings, Inc. (OWOO), closed Friday's trading session at $0.0033, down 17.50%, on 19,508,844 volume with 106 trades. The average volume for the last 60 days is 2,154,342 and the stock's 52-week low/high is $0.0018/$0.25.
Wellness Center USA, Inc. (WCUI)
PennyStocks24 and Pumps and Dumps reported this month on Wellness Center USA, Inc. (WCUI), UndiscoveredEquities, StockProfessors, PennyStockShark, USA Market News did earlier, and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Wellness Center USA, Inc. specializes in the development of Healthcare and Alternative Care solutions that improve life across North America and other emerging markets. An alternative healthcare, medical device solutions, and online nutraceutical sales enterprise, the Company has three business units. These are CNS-Wellness, Psoria-Shield, Inc., and AminoFactory. Wellness Center USA has their headquarters in Schaumburg, Illinois.
The Company’s wholly-owned subsidiary, CNS-Wellness, is a cognitive science clinic business. They specialize in the treatment of behavioral health disorders. CNS-Wellness has a minimum of three focus areas. These include stress related disorders (anxiety and panic attacks, depression, and obsessive-compulsive spectrum disorders). Another focus area is developmental and learning disorders (autistic spectrum issues and Asperser's syndrome, AD/HD, learning differences, and birth trauma-related issues). A third focus area is purely brain-based issues (epilepsy and seizure disorders, traumatic brain injuries, as well as related acquired brain syndromes).
Wellness Center USA’s wholly-owned subsidiary, Psoria-Shield, specializes in the design, manufacturing, and distribution of medical devices to domestic and global markets. Moreover, Wellness Center USA’s AminoFactory division is an online supplement store. They market and sell a broad array of high-quality nutritional vitamins and supplements.
Earlier this month, Wellness Center USA announced that Psoria-Shield's flagship product Psoria-Light® was granted full patent status from the U.S. Patent and Trademark Office (USPTO) for one of a number of patent applications, 8,481,982. Psoria-Light® emits only pure monochromatic UVA and narrow-band UVB light from deep UV LED arrangements. The device's other patent pending LED emitter technology doesn't heat the skin and doesn't carry any of the laser-specific safety concerns associated with excimer lasers.
Recently, Wellness Center USA announced that they received $1,648,500 from the sale of 4,121,250 restricted shares of the Company’s common stock to 53 individual accredited investors. Participants were granted five-year warrants to purchase a total of 4,121,250 Shares at an exercise price of $0.75 per share.
Mr. Andrew J Kandalepas, Chief Executive Officer and Chairman of Wellness Center USA, said, "We are pleased with the success of our capital raise, as it shattered our target objectives relative to time and size. This performance endorses our investor's strong belief in our business model and strategy. The capital infusion exceeds our immediate operational needs, such as production of our Psoria-Light® medical device and CNS expansion, and gives us the ability to invest in new business opportunities sooner than anticipated."
Wellness Center USA, Inc. (WCUI), closed Friday's trading session at $1.14, down 1.72%, on 40,835 volume with 67 trades. The average volume for the last 60 days is 43,440 and the stock's 52-week low/high is $0.21/$1.42.
mCig, Inc. (MCIG)
Today we are reporting on mCig, Inc. (MCIG), here at the QualityStocks Daily Newsletter.
On August 28, 2013, Lifetech Industries, Inc. announced that they changed their name to mCig, Inc. In addition, they completed a forward stock split on a 10-for-1 basis. This name change is part of an initiative led by incoming Chief Executive Officer, Mr. Paul Rosenberg, to reposition the Company and their technology through launching a new consumer product, the mCig. This product is a purpose built loose leaf electronic vaporizing cigarette (eCig).
mCig has their corporate headquarters in Bellevue, Washington. The Company’s shares trade on the OTC Bulletin Board under the new trading symbol “MCIG”, effective today, Friday, September 27, 2013. The Company’s name change and the forward stock split received approval from the Financial Industry Regulatory Authority (FINRA). The name change and forward split were effective for trading purposes on the open of business on Thursday August 29, 2013.
A technology company, mCig is concentrating on two long-term trends. One is the decriminalization and legalization of marijuana for medicinal or recreational purposes. The other is the adoption of eCigs by the globe’s 1.2 billion smokers.
mCig is preparing to introduce their first product the mCig- retailing at $10. The mCig is designed in the United States. The Company believes that this product provides a superior smoking experience through heating, not burning, plant material, waxes, and oils, to deliver a smoother inhalation experience. The Company is working toward the launch of the mCig between the end of Quarter 3 or the beginning of Quarter 4 of 2013.
The mCig was purpose built for the consumption of an array of plant materials. This is versus being pre-packaged with plant material or vapor. This allows a smoker to consume the plant material of their choice as not everybody favors nicotine. The mCig heats up plant material in under ten seconds. The mCig is of 100 percent stainless steel construction and it measures 5.7 inches by 0.36 inches. The LED indicator light on this product turns brighter as the mCig heats up. It displays the battery status when it is charging.
mCig, Inc. (MCIG), closed Friday's trading session at $0.171, up 10.32%, on 565,096 volume with 155 trades. The average volume for the last 60 days is 3,936 and the stock's 52-week low/high is $0.0048/$0.261.
BioZone Pharmaceuticals, Inc. (BZNE)
We are reporting on BioZone Pharmaceuticals, Inc. (BZNE) today, here at the QualityStocks Daily Newsletter.
Formed in 1987 by Dr. Brian Keller, BioZone Pharmaceuticals, Inc. is a developer, manufacturer, and marketer of Over-the-Counter (OTC) drugs and preparations, cosmetics, and nutritional supplements. This is on behalf of health care product marketing companies and national retailers. BioZone Pharmaceuticals is based in Englewood Cliffs, New Jersey. The Company’s shares trade on the OTC Markets’ OTCQB.
On May 16, 2011, BioZone acquired substantially all of the assets and assumed all of the liabilities of Aero, pursuant to an Asset Purchase Agreement dated as of that date. Aero manufactures, markets, and distributes a line of dermatological products under the trade name of Baker Cummins Dermatologicals. On June 30, 2011, BioZone acquired the BioZone Lab Group, which operates as a developer, manufacturer, and marketer of OTC drugs and preparations, cosmetics, and nutritional supplements.
BioZone has developed proprietary drug delivery technology (the BioZone Technology) as an enhancement for approved generic prescription drugs that are limited because of poor stability or bioavailability or variable absorption. The proprietary drug delivery technology has enabled and transformed the administration of drugs that are difficult to formulate.
BioZone Pharmaceuticals’ products include Cosmetic and Personal Care Products, such as creams, lotions, gels, ointments, cleansers, toners, masks, eye treatments, lip treatments, moisturizers, sun protection, and acne products. Products additionally include Nasal and Ear Products, including drops, sprays, liquids, lotions, and gels. Furthermore, products include Dietary Supplements including liquids, suspensions, syrups, solutions, as well as gels.
The application of BioZone's technology allows them to pursue reformulation of generic drugs and pursue a low-risk regulatory pathway for NDA approval. BioZone also provides oral, topical, and injectable drug products for anesthesia, infectious diseases, metabolic diseases, and oncology. They offer an innovative line of dermatology products for a variety of dermatological diseases.
The Company’s patented technologies include QuSomes® and LipoSpray®. QuSomes are new, revolutionary, non-phospholipid liposomes. They are suitable for cosmetic and drug formulation that render conventional liposomes obsolete. LipoSpray® is a new patented delivery technology. LipoSpray® enhances the absorption of active ingredients when sprayed into the mouth under the tongue. The liposome encapsulated active ingredients penetrate the mucosal tissue of the mouth. They are absorbed into the bloodstream and circulate throughout the body in minutes.
Earlier this month, MusclePharm Corp. (MSLP) announced that they made a $2 million strategic investment in BioZone Pharmaceuticals. MusclePharm develops and markets sports nutritional supplements that address active lifestyles.
BioZone Pharmaceuticals, Inc. (BZNE), closed Friday's trading session at $0.79, up 16.18%, on 4,349,846 volume with 929 trades. The average volume for the last 60 days is 10,877 and the stock's 52-week low/high is $0.16/$3.75.
CVSL, Inc. (CVSL)
SuperBirdStocks, MicrocapVoice, Buzz Stocks, Stock Marketing Inc., Stockpalooza, Stock Rich, StockEgg, and HotOTC reported previously on CVSL, Inc. (CVSL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Based in Plano, Texas, CVSL, Inc. is pursuing a strategy of gathering together multiple companies in the direct selling, or micro-enterprise sector. With this specific strategy, each enterprise maintains their own separate brand identity, leadership, and product line. This is while achieving efficiencies via sharing of back office resources and best practices. The product lines and sales forces of separate CVSL companies will not be mixed. All companies will benefit from shared ideas and efficiencies in the "back of the house," including finance, Information Technology (IT), as well as supply chain. CVSL lists on the OTCQB.
For Owners, a private direct selling company can partner with CVSL. The owners obtain the opportunity to monetize a portion of their holdings if they desire, for estate planning or other purposes. Moreover, for public company owners who want to gain the benefit of going private, CVSL offers a method to become part of a larger entity under an umbrella company. In addition, the Company offers an opportunity to gain valued expertise and support within an existing infrastructure for owners trying to get a new direct selling idea launched.
The first direct seller to become part of CVSL was the brand of American hand-crafted baskets and other home furnishings, The Longaberger Company, in March 2013.
Yesterday, CVSL and Agel Enterprises, LLC announced the signing of a definitive agreement for CVSL to acquire Agel Enterprises as part of CVSL’s growth strategy in the direct selling industry. Agel's approximately $37 million in annual revenue will bring CVSL's total revenue to roughly $140 million. Agel offers a line of nutritional gel supplement products in markets globally, including Europe, North America, Latin America, and Asia.
In addition to this transaction, CVSL has completed transactions with previously mentioned The Longaberger Company, a direct seller of hand-crafted baskets and home decor items; Your Inspiration At Home, an award-winning maker of spice blends from around the world; and Tomboy Tools, which offers a line of tools designed for women, as well as home security services.
CVSL, Inc. (CVSL), closed Friday's trading session at $0.388, up 9.30%, on 169,686 volume with 42 trades. The average volume for the last 60 days is 28,482 and the stock's 52-week low/high is $0.0145/$0.75.
Mass Megawatts Wind Power, Inc. (MMMW)
Penny Stocks Profile and SmallCapVoice reported previously on Mass Megawatts Wind Power, Inc. (MMMW), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Mass Megawatts Wind Power, Inc. is a leader in the development of an innovative wind power technology. They are bringing a product to the renewable energy marketplace that they indicate can produce electricity at a cost 30 percent lower than other wind power equipment. The Company holds exclusive patent rights to the Multi-Axis Turbo system (MAT) for 11 percent of the global territory, and 50 percent territorial rights in the U.S. Mass Megawatts Wind Power lists on the OTCQB. The Company has their corporate headquarters in Worcester, Massachusetts.
Their MAT technology is adaptable to high and lower wind resource areas. It is economically scalable to meet electric supply requirements from small users to large utilities. The MAT technology is the first wind power technology that allows purchasers to size their electric generation facility to fit their usage requirements.
MAT units range between 50 feet to a maximum of 80 feet in overall height. MAT units have very productive generation capabilities in regions with lower wind speeds, where 'tall tower' utility-scaled projects are not financially feasible or successful. The MAT units offer durability as well as low cost maintenance. The Company’s equipment is rated to withstand winds of up to 120 mph. All mechanical and electrical components are close to ground level. Projected maintenance costs are 50 percent less than the wind power industry's average.
Last month, the Company announced the development of a new solar tracking technology designed to increase solar energy production by 30 percent. The design of the patent pending, Mass Megawatts ‘Solar Tracking System’ (STS) is to automatically adjust the position of solar panels to receive an optimal level of direct sunlight throughout the day. The Mass Megawatts STS utilizes a low-cost structure that adds stability to the overall system while improving energy production levels.
This past Monday, Mass Megawatts Wind Power introduced a program for qualified businesses in certain states with the opportunity to generate a high rate of return of their capital investment into solar equipment. For instance, a project selling for $170,000 can anticipate $120,000 in cash realized from the investment at the end of year one. In subsequent years, over $30,000 yearly in cash can be anticipated each year for up to ten years or longer. Much of the cash realized in the first year is from incentives given to solar power equipment.
Mass Megawatts Wind Power, Inc. (MMMW), closed Friday's trading session at $0.0275, down 7.72%, on 536,285 volume with 29 trades. The average volume for the last 60 days is 165,923 and the stock's 52-week low/high is $0.011/$0.21.
Cellceutix Corp. (CTIX)
Money Morning, FeedBlitz, AllPennyStocks, and Real Pennies reported earlier on Cellceutix Corp. (CTIX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Cellceutix Corp. is a clinical stage biopharmaceutical company that lists on the OTC Markets’ OTCQB. The Company concentrates on developing and commercializing their pipeline of compounds for novel therapies in areas of serious unmet medical need. This includes cancer, psoriasis, and antibiotic applications. Cellceutix is based in Beverly, Massachusetts.
The Company’s flagship compound is Kevetrin™. This is a novel drug that the Company indicates has shown very promising laboratory data as a new cancer treatment. Clinical trials are taking place at Harvard University’s Dana-Farber Cancer Institute and partner Beth Israel Deaconess Medical Center to test Kevetrin™ against advanced solid tumors. Further studies are taking place at Beth Israel Deaconess to research Kevetrin™ in conjunction with two Pfizer multikinase inhibitors as potential new therapies for renal cancer and melanoma.
Cellceutix’ second drug in development is Prurisol, an anti-psoriasis compound. Prurisol is a small molecule acting on the principles of immune modulation and PRINS reduction. It has been found to be effective against psoriasis in animal models (in induced psoriasis and a xenograft model with human psoriatic tissue). The Company is also developing their KM-391 compound. This is a novel compound undergoing development for the treatment of autism.
This month, Cellceutix provided shareholders an update concerning the Company's recent acquisition of the assets of PolyMedix. The acquisition was announced September 9, 2013. Cellceutix acquired, to a large extent, all of the assets of PolyMedix, including multiple compounds, two of which were in clinical trials, equipment assets at the former PolyMedix headquarters, and the Intellectual Property (IP) relating to drugs in the pipeline.
Cellceutix will immediately advance the Brilacidin compound portfolio asset. The Company’s intention is to immediately advance Brilacidin into a Phase 2b clinical trial for acute bacterial skin and skin structure infections, or ABSSSI. Furthermore, Cellceutix has begun reviewing other newly acquired compounds. They see strong possibilities in PMX-10098 for fungal infections. The Cellceutix team plans to immediately begin additional research.
Cellceutix Corp. (CTIX), closed Friday's trading session at $1.89, down 0.53%, on 128,221 volume with 127 trades. The average volume for the last 60 days is 4,455 and the stock's 52-week low/high is $0.774/$2.47.
Lustros, Inc. (LSTS)
Pumps and Dumps, PennyStocks24, SmallCapVoice, AllPennyStocks, and Penny Stock Buzz reported earlier on Lustros, Inc. (LSTS), and we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Lustros, Inc. specializes in the production of Copper Sulfate from traditional mining and the treatment of copper tailings. Copper tailings are waste materials leftover from previous mining operations. In January 2012, Lustros purchased a majority stake of Sulfatos Chile SA., a Chilean private company currently involved in the manufacturing of Copper Sulfate and copper mining. Sulfatos Chile SA owns the Anica Copper Mines (600-hectare mineral property) and a copper sulfate production project.
Lustros’ shares trade on the OTC Markets’ OTCQB. The Company has their corporate headquarters in Santee, California. In addition, the Company has an office in Pudahuel, Santiago, Chile.
The Company’s Mineraltus SA subsidiary is a Chilean corporation that will process tailings of expired copper mines to secure the raw materials to manufacture high quality, food-grade copper sulfate. Mineraltus has patent-pending technology that enables them to extract the mineral content from these waste materials, and to restore this barren, inhospitable land so that it is useable for future development, parks, and more.
In 2011, Lustros' Sulfatos Chile bought an 830-hectare property (2,050 acres) in the Sierra del Cocou, Comuna de Illapel in the IV Region of Chile. The Company has dedicated 225 hectares to the construction of an industrial plant to process feed-grade Copper Sulfate. The designation of the remaining area is for future growth and the development of additional plants. The sourcing of the copper will be from their Anica Mine.
Lustros announced in December 2012 that they secured the final funding needed to complete the copper sulfate processing plant in Puerto Oscuro, Chile. This final funding enabled the Company to complete the crushing plant, leaching pads and the remaining work needed on the Sx/Cr plant. Copper sulfate (CuSO4) is a value-added product derived from copper ore.
Lustros announced in July 2013 that their subsidiary, Sulfatos Chile SpA, initiated pilot production of Pentahydrate Copper Sulfate at their multimillion-dollar, state-of-the-art facility. The plant capacity is three times its original design. This plant can process up to 15,000 tons of mineral monthly. Present permitting is at 5,000 tons monthly.
Lustros, Inc. (LSTS), closed Friday's trading session at $0.19, up 8.57%, on 327,577 volume with 33 trades. The average volume for the last 60 days is 190,180 and the stock's 52-week low/high is $0.14/$1.50.
GNCC Capital, Inc. (GNCP)
The QualityStocks Daily Newsletter would like to spotlight GNCC Capital, Inc. (GNCP). Today, GNCC Capital, Inc. closed trading at $0.0019, up 58.33%, on 35,106,152 volume with 198 trades. The stock’s average daily volume over the past 60 days is 4,308,628, and its 52-week low/high is $0.0006/$0.09.
GNCC Capital, Inc. (GNCP) is a gold and silver exploration company with six different projects, all of which were carefully selected due to their outstanding characteristics. The company’s geologists will supervise an extensive exploration program for these projects to prove up reserves through geological surveys and a substantial number of carefully planned drilling programs.
The company’s initial exploration properties, located in Arizona, consist of Esther Basin, Burnt Well, Clara Gold, Kit Carson, Silverfields, and Potts Mountain. GNCC Capital plans to create significant value for its initial properties portfolio through continued exploration and joint ventures, as well as through acquiring additional gold and silver exploration assets.
GNCC Capital currently holds circa 80% of its assets in gold exploration properties. The strong rise in gold prices over recent years make this company attractive to investors seeking to benefit from the increasing value of precious metals. Backed by a world-class management team with decades of experience in the financial and mining sectors, GNCC Capital is well positioned to capitalize on the upward trend.
The company’s focus is creating value for its shareholders, employees, and business and social partners through responsible and safe exploration, mining, and marketing. While gold exploration is the company’s main focus, GNCC Capital will take advantage of value-creating opportunities in other minerals where it can leverage existing assets, skills, and experience. Disclaimer
GNCC Capital, Inc. Company Blog
GNCC Capital, Inc. News:
GNCC Capital, Inc. -- Potential Low Cost Mining at Gold Hills Property
GNCC Capital, Inc. Completes the Acquisition of the White Hills Gold Properties
GNCC Capital, Inc. Nears Completion of the Acquisition of the White Hills Gold Properties
Mabwe Minerals Inc. (MBMI)
The QualityStocks Daily Newsletter would like to spotlight Mabwe Minerals Inc. (MBMI). Today, Mabwe Minerals Inc. closed trading at $0.37, up 23.33%, on 5,100 volume with 6 trades. The stock’s average daily volume over the past 60 days is 19,928, and its 52-week low/high is $0.06/$0.70.
Mabwe Minerals Inc. (MBMI) is a U.S. based natural resources and hard asset company focused on the mining, logistics, and commercial sales of industrial minerals and metals, with a particular emphasis on barite. The company's operations are conducted through its Zimbabwe affiliate, Mabwe Mineral Zimbabwe (Private) Ltd. Transitioning into commercial production, MBMI's company fundamentals are well positioned with virtually no debt and key strategic partnerships in place.
Along with its affiliate, Mabwe Minerals Zimbabwe (Private) Ltd., an indigenous Zimbabwe company, the company owns 100% of the mineral & metal rights to Dodge Mine. The mine will be managed by the company's minority owned partner, WGB Kinsey & Company, Zimbabwe's most experienced mining & construction company representing four generations of Kinsey leadership. Management believes WGB Kinsey & Company has all the necessary equipment and management experience to efficiently perform all the mining operations at Dodge Mine.
The Dodge Mine property consists of three hydrothermal mountains representing 123 hectares containing multiple deposits of superior-grade barite, limestone, and talc. Hydrothermal barite deposits throughout Dodge Mine represent the highest grade of new barite sources to be brought into commercial production in years. A third party oil & gas drilling sector geologist recently confirmed that the multiple barite deposits are considered "World Class" in quality and highly efficient to mine via open pit extraction following the barite veins and salvaging large percentages of barite within the halo zones via jigging systems.
With a continuing worldwide shortage of high-grade barite, Mabwe Minerals is in the right place at the right time. The company's current customer uses barite as a weighting agent in oil & gas drilling applications in the Gulf of Mexico, home to the largest concentration of active rigs in the world. Coupled with the recent massive discovery of oil & gas off the coast of neighboring Mozambique along with new drilling contracts expected in the region, MBMI is in an attractive geographical location to capture the expected demands of this emerging market. Moving from an exploration stage company into commercial barite production, Mabwe Minerals is well positioned to generate significant shareholder returns. Disclaimer
Mabwe Minerals Inc. Company Blog
Mabwe Minerals Inc. News:
Mabwe Minerals Completes Strategic Alliances With Steinbock Minerals Ltd. and Yasheya Ltd.
Mabwe Minerals Commences Mining Operations at Dodge Mine
Mabwe Minerals Frames Strategic Alliances With Steinbock Minerals Ltd. and Yasheya Ltd.
Nexus Enterprise Solutions, Inc. (NXES)
The QualityStocks Daily Newsletter would like to spotlight Nexus Enterprise Solutions, Inc. (NXES). Today, Nexus Enterprise Solutions, Inc. closed trading at $0.335, up 8.06%, on 140,343 volume with 29 trades. The stock’s average daily volume over the past 60 days is 1,212, and its 52-week low/high is $0.25/$0.31.
Nexus Enterprise Solutions, Inc. (NXES) focuses on the auto, health, and life insurance lead generation business. The company markets its services to agencies, agent networks, and insurance carriers throughout the United States. Lead campaigns are fully customizable based on the need of the buyer whether it’s geo-targeting, specific age demographics, or whatever the carrier or agency requires.
The company leverages a suite of proprietary processes and systems designed to identify customers that are more likely to grow with its clients beyond a single transaction. Nexus Enterprise is a recognized leader in providing a broad range of internet marketing strategies to capture targeted buyer data and use that data to generate revenues through both affiliate marketing and lead generation sales.
By working with multiple carriers and agencies, Nexus Enterprise ensures lead coverage throughout the United States. The company provides real-time reporting and its payment schedule can be structured either on a weekly or monthly schedule. Additionally, all traffic is hosted and run on its own landing pages and websites, which the company has done extensive A/B and multivariate testing to ensure optimization for peak performance.
The team of individuals behind Nexus Enterprise has a tremendous amount of experience and success in lead generation. Holding fast to the belief that top quality leads are necessary for a top quality company, the company’s staff implements its in-house expertise with PPC, SEO, social networking, and e-mail traffic to generate the best real-time leads for Nexus Enterprise’s growing list of clients. Disclaimer
Nexus Enterprise Solutions, Inc. Company Blog
Nexus Enterprise Solutions, Inc. News:
Nexus Enterprise Solutions, Inc. Elects Marketing Icon Stan Rapp to Board of Directors
Nexus Enterprise Solutions, Inc. Elects Gunnar Counselman to Board of Directors
Nexus Enterprise Solutions, Inc. Reports Record, 300% Increase in Insurance Leads Generated by its Proprietary NexChange Marketplace(sm)
GlobalWise Investments, Inc. (GWIV)
The QualityStocks Daily Newsletter would like to spotlight GlobalWise Investments, Inc. (GWIV). Today, GlobalWise Investments, Inc. closed trading at $0.10, up 17.65%, on 29,150 volume with 6 trades. The stock’s average daily volume over the past 60 days is 30,783, and its 52-week low/high is $0.05/$0.65.
GlobalWise Investments, Inc. (GWIV), via wholly-owned subsidiary Intellinetics, Inc., is a leading-edge technology company focused on Enterprise Content Management (ECM) solutions for the digital age. The ECM industry continues to grow rapidly as a result of unrestricted proliferation of digital content within today's business environment. Leveraging its proprietary cloud-based computing software, GlobalWise is poised to capture a significant market share of this burgeoning industry.
GlobalWise's ECM service is delivered to customers via five unique delivery models which cover the spectrum of business needs: Cloud/Saas (Software as a Service), Hardware Vendor Integrated Service, Software Vendor Integrated Service, Premise (Client-Server), Hybrid (Premise & Cloud/Saas).This diversity gives advanced security & privacy features with an on-demand structure needed for large Tier 3 and Tier 4 businesses that are currently underserved by the market.
The Intellinetics platform defines a new industry benchmark and game-changing approach by combining advanced virtualization & automated content management with an open and service-oriented architecture using web services. The company provides strategies, tactics, and technologies used to manage paper and digital assets from capture to long-term archive, without the need for manual processes conducted by a full time employee.
GlobalWise's management boasts a combined total of over 60 years in ECM leadership and industry experience. The ECM industry is expected to exceed $5.1 billion by 2013 with Gartner predicting a compound annual growth rate of 9.5%. IBM Market Insights predicts adoption of cloud computing to grow by 26% CAGR between 2010 through 2013. Leveraging management and key department heads, Intellinetics has a strong foundation from which to capture significant market share within the lucrative $149 billion Business Software & Services industry. Disclaimer
GlobalWise Investments Company Blog
GlobalWise Investments News:
GlobalWise Investments Announces Appointment of a New Board Member
GlobalWise to Present at Solutions Exchange Conference
GlobalWise Investments Reports Financial Results for Second Quarter 2013
StreamTrack, Inc. (STTK)
The QualityStocks Daily Newsletter would like to spotlight StreamTrack, Inc. (STTK). Today, StreamTrack, Inc. closed trading at $0.083, even for the day. The stock’s average daily volume over the past 60 days is 2,943, and its 52-week low/high is $0.051/$2.50.
StreamTrack, Inc. (STTK), a digital media and technology services company, provides audio and video streaming and advertising services through its RadioLoyalty™ Platform to a global group of internet and terrestrial radio stations, internet radio guides, and other broadcast content providers. The company's platform powers a web-based and mobile player that manages streaming audio and video content, social media engagement, and ad serving.
StreamTrack offers its platform directly to broadcasters and integrates or white labels its technologies with web-based internet radio guides and other web-based content providers. With StreamTrack technology, broadcasters and publishers are able to maximize their revenue while decreasing expenses, while advertisers are provided with a cost-effective means to reach their target audience from one source at scale.
WatchThis™, StreamTrack's patent-pending technology designed to provide web, mobile, and IP television streaming services that are e-commerce enabled within streamed content, could revolutionize the entertainment industry by combining original network content with interactive product placement. Recognizing the convergence of traditional televised advertisement and internet technology, StreamTrack is advancing its WatchThis™ technology to lead the revolution taking place.
StreamTrack is dedicated to continually creating and managing innovative technology products to provide broadcasters and content owners the most advanced solutions available in the marketplace. Fully committed to also increasing and protecting shareholder value, the management team carefully executes operational, development, and marketing programs with the primary aim of maximizing the company's growth potential and profitability. Disclaimer
StreamTrack, Inc. Company Blog
StreamTrack, Inc. News:
StreamTrack Announces Cancellation of Potential $2.5 Million Royalty Liability
StreamTrack's RadioLoyalty Signs TargetSpot
StreamTrack's RadioLoyalty Platform™ Adds Over 3,000 Stations
Singlepoint, Inc. (SING)
The QualityStocks Daily Newsletter would like to spotlight Singlepoint, Inc. (SING). Today, Singlepoint, Inc. closed trading at $0.0042, even with yesterday's close, on 300,973 volume with 6 trades. The stock’s average daily volume over the past 60 days is 1,468,355, and its 52-week low/high is $0.0025/$0.03.
Singlepoint, Inc. (SING) is a state-of-the-art mobile technology company and full-service mobile marketing agency. The company’s mobile commerce and communication platform allows clients to conduct business transactions, accept donations, and engage in targeted communication campaigns with their customers/donors through mobile devices.
The company is known for making any campaign instantly interactive via the mobile phone, enabling non-profit and for-profit organizations send more messages, create more awareness, and raise revenues and donations. The SinglePoint brand has been associated with media messaging campaigns for NBC, MTV, CBS, Univision and other top corporate entities.
Today, approximately 150 million web-enabled mobile phones exist in our nation alone. Javelin Strategy and Research predicts the highest growth for any payment type from now until 2018 will be in mobile payments. Rapid mobile adoption and the industry-wide push for mobile payments are anticipated to increase the total amount of mobile payments at point of sale to $5.4 billion in 2018.
SinglePoint is well positioned to capitalize on the growing mobile technology space. Key partnerships with companies such as Text2Bid, a leader in mobile auction technology, solidify the company’s foothold in the industry and provide multiple avenues for ongoing expansion. Moving forward with a solid business plan and carefully assembled management team, SinglePoint is poised for rapid growth. Disclaimer
Singlepoint, Inc. Company Blog
Singlepoint, Inc. News:
Singlepoint, Inc. Secures Partnership, Sales Rights with Mobile Auction Expert, Text2Bid™
SinglePoint, Inc. Partners with iATS Payments
Singlepoint, Inc. Announces Name/Symbol Change; Launches Dynamic Corporate Website toward Increased Customer Base and Revenue Streams
Intelimax Media, Inc. (IXMD)
The QualityStocks Daily Newsletter would like to spotlight Intelimax Media, Inc. (IXMD). Today, Intelimax Media, Inc. closed trading at $0.035, even for the day. The stock’s average daily volume over the past 60 days is 30,661, and its 52-week low/high is $0.035/$0.39.
Intelimax Media, Inc. (IXMD) is a digital entertainment company specializing in fantasy sports, social gaming, entertainment, and software solutions. Primarily focused on the daily fantasy sports and social gaming sectors, the company is applying its advanced technologies to fully capitalize on the convergence of key trends in the ever-expanding social gaming space.
The company’s team of experts has identified key opportunities in the rapidly emerging daily fantasy sports and social media sectors. Leveraging its proprietary DraftTeam.com platform, the company is generating multiple revenue streams. Innovative plans for international expansion are underway to maximize exposure and traffic through various online and mobile channels.
It's estimated by the Fantasy Sports Trade Association that over 40 million people play some form of a fantasy sport each year in North America. Participation has grown over 30 percent annually the past four years with 19 percent of all males in the U.S. playing fantasy sports. Fantasy sports are estimated to have a $4–$5 billion annual economic impact across the sports industry.
Intelimax Media offers exciting and entertaining online brands that attract a loyal audience and in turn facilitate lucrative revenues from management fees, product placement, and software sales. Backed by personnel with a proven track record in the finance, growth and development of successful companies, the company is poised for rapid growth in the Internet and entertainment sectors.
Intelimax Media also trades on the Canadian market under the symbol (IMD). Disclaimer
Intelimax Media, Inc. Company Blog
Intelimax Media, Inc. News:
Intelimax Launches New Daily Fantasy Sports Platform on DraftTeam.com
Intelimax - Corporate Update
Grant of Stock Options
VistaGen Therapeutics, Inc. (VSTA)
The QualityStocks Daily Newsletter would like to spotlight VistaGen Therapeutics, Inc. (VSTA). Today, VistaGen Therapeutics, Inc. closed trading at $0.6101, off by 1.60%, on 11,960 volume with 9 trades. The stock’s average daily volume over the past 60 days is 2,219, and its 52-week low/high is $0.50/$0.95.
VistaGen Therapeutics, Inc. (VSTA) is a biotechnology company applying stem cell technology for drug rescue and cell therapy. Drug rescue combines human stem cell technology with modern medicinal chemistry to generate new chemical variants ("drug rescue variants") of once-promising drug candidates that have been discontinued during late-stage preclinical development due to heart or liver safety concerns. VistaGen also focuses on cell therapy, or regenerative medicine, which includes repairing, replacing or restoring damaged tissues or organs.
VistaGen's versatile stem cell technology platform, Human Clinical Trials in a Test Tube™, has been developed to provide clinically relevant predictions of potential heart and liver toxicity of promising new drug candidates long before they are ever tested on humans.
By more closely approximating human biology than conventional animal studies and other nonclinical techniques and technologies currently used in drug development, VistaGen's human stem cell-based bioassay systems can improve the predictability of the drug development cycle and lower the cost of new drug research and development by identifying product failures earlier in the cost curve. According to the Food and Drug Administration even only a ten percent improvement in predicting failure before clinical trials could save $100 million in development costs, which savings ultimately could be passed on to patients.
Using mature human heart cells produced from stem cells, VistaGen has developed and internally validated CardioSafe 3D™, a novel three-dimensional (3D) bioassay system for predicting the in vivo cardiac effects of new drug candidates before they are tested in humans. VistaGen is now focused on using CardioSafe 3D™ to generate up to two new, safer small molecule drug rescue variants every twelve to eighteen months. VistaGen anticipates that these drug rescue variants will be modified versions of once-promising new drug candidates that have been discontinued by pharmaceutical companies and academic research institutions because of heart toxicity concerns, despite substantial prior investment and positive efficacy data demonstrating their potential therapeutic and commercial benefits. In most cases, VistaGen plans to license or sell its new, safer drug rescue variants in strategic partnering arrangements with global pharmaceutical companies, arrangements providing VistaGen with both near term and downstream milestone payments and economic participation rights but without future development cost obligations.
AV-101, VistaGen's lead small molecule prodrug candidate has successfully completed Phase I clinical development in the U.S. for treatment of neuropathic pain, a serious and chronic condition affecting millions of people worldwide, depression, and other neurological diseases and conditions. To date, the U.S. National Institutes of Health (NIH) has awarded VistaGen over $8.75 million for development of AV-101. Management anticipates strategically out-licensing AV-101 to a development and marketing partner in 2013.
Neuropathic pain affects approximately 1.8 million people in the U.S. alone. Although the current active AV-101 IND is for the treatment of neuropathic pain, VistaGen's development plan and regulatory strategy for AV-101 has been designed to allow its Phase 1 safety studies to support Phase 2 development for depression, epilepsy, Huntington's Disease and Parkinson's disease, indications for which there is now supporting preclinical efficacy data. To date, VistaGen has been awarded over $8.5 million from the U.S. National Institutes of Health (NIH) for development of AV-101.
VistaGen is also developing LiverSafe 3D™, a novel predictive liver toxicity and drug metabolism bioassay system for drug rescue applications. In parallel with drug rescue activities, the Company is funding early-stage nonclinical studies focused on potential cell therapy applications of its Human Clinical Trials in a Test Tube™ platform. Disclaimer
VistaGen Therapeutics, Inc. Company Blog
VistaGen Therapeutics, Inc. News:
VistaGen Provides Update on $36 Million Strategic Financing Agreement
VistaGen Therapeutics Presents CardioSafe 3D™ and LiverSafe 3D™ Developments at International Society of Stem Cell Research's 11th Annual Meeting
VistaGen Therapeutics and Duke University Publish Results on Production of Functional 3D Human Heart Tissue
Today's Top 3
Investor News Source
Mad Money Picks
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Advaxis, Inc. (ADXS) Lead Product Candidate ADXS-HPV in Combination with PD-1 Antibody Significantly Improves Immune and Therapeutic Efficacy in Preclinical Study
- Calpian, Inc. (CLPI) CEO Harold Montgomery Discusses the Company’s Indian Subsidiary, Money-on-Mobile, to Viewers of CorporateProfile.com
- Consorteum Holdings, Inc. (CSRH) Forms a New, Wholly Owned Subsidiary
- DoMark International, Inc. (DOMK) Increases Holding in Imagic Ltd. Ahead of SmartLink Global Launch
- Dragon Capital Group Corp. (DRGV) Subsidiary to Participate in National Science and Technology Research Project Focusing on Large Scale Programmable Logic Controllers
- Epazz Inc. (EPAZ) Short Interest in Market Climbs; Short Interest in Excess of 47 Percent of Total Volume for Sep 2013
- GlobalWise Investments, Inc. (GWIV) to Present at Provider Resources Group 2013 Business Development Conferences
- GNCC Capital, Inc. (GNCP) Potential Low Cost Mining at Gold Hills Property
- Intelimax Media, Inc. (IXMD) Launches New Daily Fantasy Sports Platform on DraftTeam.com
- International Stem Cell Corp. (ISCO) to Present at 12th Annual BIO Investor Forum October 8-9th, 2013
- Mabwe Minerals Inc. (MBMI) Completes Strategic Alliances With Steinbock Minerals Ltd. and Yasheya Ltd.
- Max Sound Corp. (MAXD) CEO Featured in Equities.com Interview
- Midwest Energy Emissions Corp. (MEEC) to Present at the Southern California Investor Conference
- NanoTech Entertainment, Inc. (NTEK) Announces the Opening of 4K Studios
- Nexus Enterprise Solutions, Inc. (NXES) Elects Marketing Icon Stan Rapp to Board of Directors
- On The Move Systems Corp. (OMVS) Signs New Agreement to Expand Partner Portfolio
- OxySure Systems, Inc. (OXYS) to Exhibit at the National Safety Council's (NSC) 2013 Congress & Expo
- PITOOEY!, Inc. (PTOO) Reports Substantial Customer Base Growth
- Raptor Resources Holdings Inc. (RRHI) Mabwe Minerals Commences Mining Operations at Dodge Mine
- Singlepoint, Inc. (SING) Acquires Assets, $1m+ in Revenues of Six Sigma Services, Inc.
- Solar Wind Energy Tower, Inc. (SWET) Wall Street Transcript Interview with Ronald W. Pickett, the President, CEO and Chairman of Solar Wind Energy Tower, Inc.
- StreamTrack, Inc. (STTK) Announces Cancellation of Potential $2.5 Million Royalty Liability
- VistaGen Therapeutics, Inc. (VSTA) Provides Update on $36 Million Strategic Financing Agreement